Fig. 3

ICER scatterplot generated by MonteCarlo simulation. The ICER is €29,002/QALY. The model has been run 10,000 times. In 35% of cases dexamethasone is more expensive and provides more QALYs than aflibercept and in 31% of cases, dexamethasone is less expensive and provides less QALYs than aflibercept. In quadrant II it is showed that in 8% of cases dexamethasone is more expensive and provides less QALYs than aflibercept and in quadrant IV 26% of cases resulted, which means that dexamethasone is less expensive but provides more QALYs